Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bronstein

Showing results (111-120 of 164) with videos related to

Pageof 17
Sort By:
Pituitary|August 9, 2014
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III studyMichael Sheppard, Marcello D Bronstein, Pamela Freda, et al.
Nature Reviews. Endocrinology|July 28, 2018
A Consensus Statement on acromegaly therapeutic outcomesShlomo Melmed, Marcello D Bronstein, Philippe Chanson, et al.
JSES International|March 11, 2024
Arthroscopic subacromial decompression improved outcomes in situationally depressed patients compared to clinically depressed or nondepressed patientsDylan N Greif, Hashim J F Shaikh, James Neumanitis, et al.
ACS Nano|March 12, 2019
Designing Janus Ligand Shells on PbS Quantum Dots using Ligand-Ligand CooperativityNoah D Bronstein, Marissa S Martinez, Daniel M Kroupa, et al.
Pituitary|September 18, 2015
SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot studyAndrea Giustina, John S Bevan, Marcello D Bronstein, et al.
Journal of Endocrinological Investigation|May 10, 2020
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III studyA Lacroix, M D Bronstein, J Schopohl, et al.
Pituitary|March 31, 2009
Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatmentAna Paula M Casarini, Raquel S Jallad, Emília M Pinto, et al.
European Journal of Endocrinology|March 29, 2020
Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA studyAnnamaria Colao, Marcello D Bronstein, Thierry Brue, et al.
Lipids|August 4, 2001
Plasma cholesteryl ester transfer protein and lipoprotein levels during treatment of growth hormone-deficient adult humansA J Carrilho, M B Cunha-Neto, V S Nunes, et al.
Molecular Cancer|January 16, 2007
PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropesCarolina Cristina, Graciela S Díaz-Torga, Rodolfo G Goya, et al.
Pageof 17

Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
Pituitary|August 9, 2014
Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III studyMichael Sheppard, Marcello D Bronstein, Pamela Freda, et al.
Nature Reviews. Endocrinology|July 28, 2018
A Consensus Statement on acromegaly therapeutic outcomesShlomo Melmed, Marcello D Bronstein, Philippe Chanson, et al.
JSES International|March 11, 2024
Arthroscopic subacromial decompression improved outcomes in situationally depressed patients compared to clinically depressed or nondepressed patientsDylan N Greif, Hashim J F Shaikh, James Neumanitis, et al.
ACS Nano|March 12, 2019
Designing Janus Ligand Shells on PbS Quantum Dots using Ligand-Ligand CooperativityNoah D Bronstein, Marissa S Martinez, Daniel M Kroupa, et al.
Pituitary|September 18, 2015
SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot studyAndrea Giustina, John S Bevan, Marcello D Bronstein, et al.
Journal of Endocrinological Investigation|May 10, 2020
Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III studyA Lacroix, M D Bronstein, J Schopohl, et al.
Pituitary|March 31, 2009
Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatmentAna Paula M Casarini, Raquel S Jallad, Emília M Pinto, et al.
European Journal of Endocrinology|March 29, 2020
Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA studyAnnamaria Colao, Marcello D Bronstein, Thierry Brue, et al.
Lipids|August 4, 2001
Plasma cholesteryl ester transfer protein and lipoprotein levels during treatment of growth hormone-deficient adult humansA J Carrilho, M B Cunha-Neto, V S Nunes, et al.
Molecular Cancer|January 16, 2007
PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropesCarolina Cristina, Graciela S Díaz-Torga, Rodolfo G Goya, et al.
Pageof 17